advertisement
Panarelli JF 21
Showing records 1 to 21 | Display all abstracts from Panarelli JF112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Panarelli JF
Ophthalmology 2024; 131: 266-276
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
Panarelli JF
Journal of Glaucoma 2023; 32: 999-1005
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
McGlumphy EJ
Ophthalmology. Glaucoma 2024; 7: 116-122
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
Bowden EC
Journal of Glaucoma 2023; 32: 999-1005
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Moster MR
Ophthalmology 2024; 131: 266-276
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Do A
Ophthalmology. Glaucoma 2024; 7: 116-122
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Garcia-Feijoo J
Ophthalmology 2024; 131: 266-276
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
Tepedino ME
Journal of Glaucoma 2023; 32: 999-1005
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Du A; Craven ER
Ophthalmology. Glaucoma 2024; 7: 116-122
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Flowers BE
Ophthalmology 2024; 131: 266-276
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
Odani-Kawabata N; Pei Z
Journal of Glaucoma 2023; 32: 999-1005
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Geyman LS
Ophthalmology. Glaucoma 2024; 7: 116-122
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Baker ND
Ophthalmology 2024; 131: 266-276
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Shen L
Ophthalmology. Glaucoma 2024; 7: 116-122
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Barnebey HS
Ophthalmology 2024; 131: 266-276
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
McLaurin EB
Journal of Glaucoma 2023; 32: 999-1005
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Grover DS
Ophthalmology 2024; 131: 266-276
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Schuman JS
Ophthalmology. Glaucoma 2024; 7: 116-122
112240 Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
Ropo A
Journal of Glaucoma 2023; 32: 999-1005
112668 Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent
Panarelli JF
Ophthalmology. Glaucoma 2024; 7: 116-122
112812 Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
Khatana AK; Lee B; Nguyen T; Stiles MC; Sadruddin O; Khaw PT;
Ophthalmology 2024; 131: 266-276
